Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Esprit

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune SystemWout De Mey, Arthur Esprit, Kris Thielemans, et al.
Vaccines|December 23, 2020
Neo-Antigen mRNA VaccinesArthur Esprit, Wout de Mey, Rajendra Bahadur Shahi, et al.
Frontiers in Immunology|June 19, 2025
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purificationArthur Esprit, Dorien Autaers, Kris Thielemans, et al.
Molecular Therapy. Nucleic Acids|July 17, 2025
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validationArthur Esprit, Dorien Autaers, Ilke Aernout, et al.
Frontiers in Immunology|March 2, 2023
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8<sup>+</sup> T cellsWout de Mey, Hanne Locy, Kirsten De Ridder, et al.
Molecular Therapy. Oncology|December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumorsFien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A synthetic DNA template for fast manufacturing of versatile single epitope mRNAWout de Mey, Phaedra De Schrijver, Dorien Autaers, et al.
Vaccines|January 22, 2024
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune SystemWout De Mey, Arthur Esprit, Kris Thielemans, et al.
Vaccines|December 23, 2020
Neo-Antigen mRNA VaccinesArthur Esprit, Wout de Mey, Rajendra Bahadur Shahi, et al.
Frontiers in Immunology|June 19, 2025
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purificationArthur Esprit, Dorien Autaers, Kris Thielemans, et al.
Molecular Therapy. Nucleic Acids|July 17, 2025
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validationArthur Esprit, Dorien Autaers, Ilke Aernout, et al.
Frontiers in Immunology|March 2, 2023
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8<sup>+</sup> T cellsWout de Mey, Hanne Locy, Kirsten De Ridder, et al.
Molecular Therapy. Oncology|December 11, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumorsFien Meeus, Arne Van der Vreken, Dorien Autaers, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A synthetic DNA template for fast manufacturing of versatile single epitope mRNAWout de Mey, Phaedra De Schrijver, Dorien Autaers, et al.
Vaccines|January 22, 2024
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.
Pageof 1